Securities Fraud Class Action Lawsuit Against PACS Group, Inc. Investor Alert
Investor Alert: Securities Fraud Lawsuit Filed Against PACS Group, Inc.
A recent update for investors: The law firm of Kessler Topaz Meltzer & Check, LLP has informed investors about a securities fraud class action lawsuit filed against PACS Group, Inc. (PACS). This lawsuit is on behalf of investors who bought PACS common stock during their April 11, 2024 initial public offering (IPO) or held securities between April 11, 2024, and November 5, 2024.
The lawsuit deadline is January 13, 2025. If you have experienced losses with PACS and would like more information, you can visit this link: https://www.ktmc.com/new-cases/pacs-group-inc?utm_source=PR&utm_medium=link&utm_campaign=pacs&mktm=r. You can also contact attorney Jonathan Naji, Esq. at (484) 270-1453 or via email at info@ktmc.com.
The complaint alleges that PACS made false statements and failed to disclose significant details about their business operations. Allegations include engaging in Medicare fraud, overbilling unnecessary therapies, and falsifying documentation, leading to misleading statements about the company’s financial health.
Investors in PACS have until January 13, 2025, to seek lead plaintiff representation through Kessler Topaz Meltzer & Check, LLP or other legal counsel. You can find more details or sign up for the case through this link: https://www.ktmc.com/new-cases/pacs-group-inc?utm_source=PR&utm_medium=link&utm_campaign=pacs&mktm=r.
Kessler Topaz Meltzer & Check, LLP is known for handling class action lawsuits nationwide, with a focus on protecting investors from fraud and misconduct. For more information about their work, visit www.ktmc.com.
If you’ve experienced significant losses with PACS, it’s essential to reach out to Kessler Topaz Meltzer & Check, LLP for more information on how to proceed. You can contact Jonathan Naji, Esq. at (484) 270-1453 or via email at info@ktmc.com for assistance.
This content may be legally relevant in some jurisdictions. Past results do not guarantee future outcomes. For the original press release, visit https://www.newsfilecorp.com/release/231109.
